Delic Holdings Corp a leader in new medicines and treatments for a modern world, is pleased to announce that it completed the sale of 1,240 units at a price of $1,000 per Unit for aggregate gross proceeds of $1,240,000, on July 27, 2022

Ketamine Wellness Centers (KWC) Approaches 100,000 Treatments, Expands FDA-Approved SPRAVATO® to Minneapolis, Salt Lake City, Dallas with More Locations Soon

The Cannabis Scientist Power List is an annual recognition of the most important innovators within the cannabis industry. Dr. Roggen has been named to the list for the third consecutive year.

Nation’s Largest Ketamine Therapy Provider Offers Complimentary Patient Resource Supporting Holistic Mental Health Treatment

Matt Stang, CEO and Co-Founder of Delic Corp, will discuss the company’s strategic outlook for the remainder of the year and the latest developments at the nation’s largest ketamine provider, Ketamine Wellness Centers (KWC)

Dr. Markus Roggen, President and Chief Scientific Officer of Delic Labs, will discuss the advancement of psychedelics as well as improvements of cannabis extraction technology during the Grow Up Conference and Expo in Victoria, British Columbia on Ju

Largest Ketamine Provider in the U.S. Now Offering FDA-Approved Esketamine Nasal Spray Offering for Adults in Six Cities

Delic Corp has filed its annual financial statements, management’s discussion and analysis, and related certifications for the year ended December 31, 2021

Delic Corp is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders.